NCT06866769 (EVAR-markers) is a clinical trial of CTA in Abdominal Aortic Aneurysm Without Rupture, sponsored by Instituto de Investigacion Sanitaria La Fe.

Who is sponsoring NCT06866769?

NCT06866769 is sponsored by Instituto de Investigacion Sanitaria La Fe.

What drugs are being tested in NCT06866769?

Interventions in NCT06866769: CTA.

What condition does NCT06866769 study?

NCT06866769 studies Abdominal Aortic Aneurysm Without Rupture.

Is NCT06866769 still recruiting?

NCT06866769 is currently recruiting now. Last updated 10 March 2025.

Last reviewed 2025-03-10 · How we verify

NCT06866769: EVAR-markers

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR

Recruiting now Last updated 10 March 2025

What this trial tests

trial testing CTA in Abdominal Aortic Aneurysm Without Rupture in 60 participants. Currently enrolling.

Timeline

25 July 2024

Primary endpoint
30 July 2025

30 April 2028

Quick facts

Lead sponsor	Instituto de Investigacion Sanitaria La Fe
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	60
Start date	25 July 2024
Primary completion	30 July 2025
Estimated completion	30 April 2028
Sites	1 location across Spain

Drugs / interventions tested

Conditions studied

Abdominal Aortic Aneurysm Without Rupture — all drugs for Abdominal Aortic Aneurysm Without Rupture →

Sponsor

Instituto de Investigacion Sanitaria La Fe — full company profile →

Who can join

18 and older, any sex, with Abdominal Aortic Aneurysm Without Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational study evaluates the efficacy of contrast-enhanced ultrasound and biomarker determination in the follow-up of patients with abdominal aortic aneurysm (AAA) treated with Endovascular Aneurysm Repair (EVAR). Currently, computed tomography angiography (CTA) is the standard for follow-up, although it has disadvantages such as radiation exposure and the use of iodinated contrasts. Contrast-enhanced ultrasound (CEUS), free of radiation and nephrotoxicity, and biomarkers could reduce the need for CTA minimizing the associated risks. Biomarkers will be measured before and after EVAR and CEUS will be performed at various time points and compared with CTA results to validate concordance and effectiveness in detecting endoleaks and aneurysm remodeling. The objectives include determining the efficacy of these combined methods and establishing a follow-up protocol that reduces exposure to radiation and iodinated contrast agents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CTA

Trials testing the same drug.

NCT03373123 — Radiomics-based Surrogate of Endoscopy (rEndosc) (CHESS1703) · NA · withdrawn
NCT03138915 — Radiomics Signature of Hepatic Venous Pressure Gradient (rHVPG) With CT Angiography (CHESS1701) · NA · completed
NCT05629000 — Optimization Strategy of Carotid Artery Stenosis · recruiting

Other recruiting trials for Abdominal Aortic Aneurysm Without Rupture

Currently open trials in the same condition.

NCT06332911 — Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair · recruiting
NCT04894864 — Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair · Phase 4 · recruiting
NCT03298477 — EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study · NA · active not recruiting

Other Instituto de Investigacion Sanitaria La Fe trials

Trials by the same sponsor.

NCT07402083 — Administration of Extracellular Vesicles From Donor Human Milk in Preterm Infants · recruiting
NCT07238608 — Impact of UFPs and MNPs on Fetal Health · recruiting
NCT06950996 — A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and · completed
NCT07478445 — Home Rehabilitation After Hip Fracture · completed
NCT05942209 — ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06866769 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigacion Sanitaria La Fe
Last refreshed: 10 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06866769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing